These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Topical salicylate therapy (4-ASA and 5-ASA enemas). Ginsberg AL Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990 [TBL] [Abstract][Full Text] [Related]
6. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease. Segars LW; Gales BJ Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685 [TBL] [Abstract][Full Text] [Related]
7. Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update. Martin F Dig Dis Sci; 1987 Dec; 32(12 Suppl):57S-63S. PubMed ID: 2891469 [TBL] [Abstract][Full Text] [Related]
8. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. Kam L; Cohen H; Dooley C; Rubin P; Orchard J Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990 [TBL] [Abstract][Full Text] [Related]
9. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease. Bonapace CR; Mays DA Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055 [TBL] [Abstract][Full Text] [Related]
10. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Habal FM; Greenberg GR Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391 [TBL] [Abstract][Full Text] [Related]
11. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A; Spinella S; Levenstein S; Prantera C Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine and 5-ASA compounds. Allgayer H Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468 [TBL] [Abstract][Full Text] [Related]
14. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease. van Hees PA Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723 [No Abstract] [Full Text] [Related]
16. New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease. Robinson MG Gastroenterol Clin North Am; 1989 Mar; 18(1):43-50. PubMed ID: 2646221 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. Klotz U; Maier K; Fischer C; Heinkel K N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853 [TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development. Peppercorn MA Ann Intern Med; 1984 Sep; 101(3):377-86. PubMed ID: 6147110 [TBL] [Abstract][Full Text] [Related]
19. Sulfasalazine and new analogues. Friedman G Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653 [No Abstract] [Full Text] [Related]
20. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA]. Jo Y; Matsumoto T; Iida M Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]